Covaxin is safe and will protect against mutants, says Bharat Biotech

The Drug Controller General of India (DCGI) had on Sunday granted restricted use approval “in clinical trial mode” to Covaxin “in the public interest”. However, the regulator did not say whether the approval had been granted on the basis of efficacy data. 

from Zee News :India National https://ift.tt/3b7fZbE
via

• Tweet
• Share
• Share
• Share
• Share

Related Post